33
Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment Pamela Hebbard August 11, 2005

Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

  • Upload
    ardice

  • View
    83

  • Download
    0

Embed Size (px)

DESCRIPTION

Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment. Pamela Hebbard August 11, 2005. Prophylaxis . Scenario 1. You are going through consent with a 60 y.o. F going for laparotomy for non-resolving SBO. - PowerPoint PPT Presentation

Citation preview

Page 1: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Venous Thromboembolism in the Surgical Patient:

Prophylaxis and Treatment

Pamela HebbardAugust 11, 2005

Page 2: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Prophylaxis

Page 3: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 1

You are going through consent with a 60 y.o. F going for laparotomy for non-resolving SBO. What is the risk of VTE in the average general surgery patient without prophylaxis?– A. 10% DVT, 0.001% fatal PE– B. 5% DVT, 0.01% fatal PE– C. 25% DVT, 0.05% fatal PE– D. 50% DVT, 1% fatal PE

Page 4: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Incidence

In general surgery patients without prophylaxis:– 15 - 30% DVT– 0.2% - 0.9% fatal PE

Risk is higher with pelvic surgery, cancer surgeryOf all surgery orthopedic surgery carries the highest risk, at 50-60% DVT

Page 5: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 2

52 y.o. F going for R hemicolectomy for cecal cancer. What will you choose for VTE prophylaxis?– A. aspirin to start post-op– B. a low-dose heparin– C. mechanical compression device/stockings– D. warfarin to start post-op– E. some combination of the above

Page 6: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Methods of Prophylaxis

1. Aspirin• 20% risk reduction compared to placebo (5

trials)

2. Graded compression stockings• 44% risk reduction• Knee-length equally effective and easier to use

than thigh-length• Need to be fitted for them

Page 7: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Methods of Prophylaxis

3. Heparins• Low-molecular weight and unfractionated• ~70% risk reduction• Equally effective• Risk of bleeding related to dose (LMWH)

Page 8: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Methods of Prophylaxis

4. Intermittent pneumatic compression• 88% risk reduction• equally effective as heparin• Probably better than stockings• From small, older studies• Also need to be fitted and requires equipment

Page 9: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Methods of Prophylaxis

5. Warfarin• does have a risk reduction• Older studies, mostly orthopedics• Impractical

6. Heparin + mechanical method• Stockings + LDUH have been shown to

enhance protection from VTE by a further 75% (from 15% to 4%).

Page 10: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 3

You have chosen to use a heparin as VTE prophylaxis for your post-op patient with cecal ca. Exactly what order will you write?

• A. heparin 5000 u sc bid• B. heparin 5000 u sc tid• C. heparin 15000 u sc bid• D. heparin ACS/DVT protocol• E. enoxaparin 30mg sc bid• F. enoxaparin 40 mg sc od• G. enoxaparin 80 mg sc bid (1 mg/kg)• H. enoxaparin 120 mg sc od (1.5 mg/kg)

Page 11: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Heparin Dosing-Prophylaxis

Unfractionated heparin:– 5000 u bid/tid

Lovenox:– 30 mg sc bid– 40 mg sc od**

Page 12: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 4

Patient 1: 20 y.o. M - inguinal hernia repairPatient 2: 60 y.o. M - APR

What post-op orders will you write?• A. no heparin for either• B. heparin for both• C.1 - none, 2 - heparin• D.1 - heparin bid, 2 - heparin tid

Page 13: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Risk Stratification

Low - Risk• “Minor” surgery • <40 y.o• No additional risk factors

Recommendation• Early ambulation only

Page 14: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Risk Stratification

Moderate Risk– Minor surgery in patients with additional risk factors– Any surgery in pts aged 40-60 w/o additional risk

factors– Major surgery in patients <40 y.o w/o additional

risk factorsRecommendation

• Heparin 5000 bid• LMWH <= 3400 IU/day (Lovenox 30mg od)• May consider stockings if contraindication to heparin

Page 15: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Risk Stratification

High Risk• Multiple risk factors• age > 60 y.o.• Age 40-60 y.o. with an additional risk

Recommendation• Heparin 5000 tid• LMWH >3400 IU/day (Lovenox 40mg od or

more)

Page 16: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Risk Stratification

Very High Risk• Major surgery in >40 y.o. with: cancer, previous

VTE, or known hypercoagulable state• Major ortho surgery, elective neurosurgery,

multiple trauma, acute SCI

Recommendation• High risk heparin dosing + stockings/ IPC

Page 17: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 5

You are going to give your pt heparin prophylaxis for major abdominal surgery. When do you give the first does?

• A. 2 hrs pre-op• B. in recovery room• C. once up to the floor• D. after the epidural comes out

Page 18: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Timing

Optimal timing is 2 hrs pre-opDVT’s begin intra-operativelyTiming may need to be adjusted if neuraxial anesthesia is being used (no strict guidelines?)

Page 19: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 6

Consider again your patient with colon cancer. How long should you continue her VTE prophylaxis?

• A. until ambulating• B. 7 days• C. until discharge• D. 4 weeks• E. 6 months

Page 20: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Timing

For most patients, heparin until ambulating well is satisfactory.For high risk patients, heparin should continue for 7-10 days minimumAbdominal or pelvic surgery for cancer: 4 weeks of LMWH reduces the incidence of DVT compared to 1 week.

Page 21: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Treating DVT/PE

Page 22: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 7

Your post-op patient is noted to have a swollen firm left calf. U/S documents proximal DVT. What is your initial treatment?

• A. heparin 5000 u sc tid• B. heparin ACS/DVT protocol• C. enoxaparin 30mg sc bid• D. enoxaparin 80 mg sc bid (1 mg/kg)• E. enoxaparin 120 mg sc od (1.5 mg/kg)

Page 23: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Initial Treatment

Choice of heparin infusion or LMWH scBoth shown to be equally effective and safeSame treatment for DVT and PELMWH easier to administer, cheaper--assuming no contraindications

Page 24: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Initial Treatment

Start warfarin at same time as heparinContinue heparin for at least 5 days and INR 2-3Out-patient therapy is equally as safe as in-hospital treatment

Page 25: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 8

70 y.o. M post-op from Hartmann’s for diverticulitis. DVT post-op. PHx DM, HTN, CAD, and stroke. How long does he continue on warfarin?– A. 3 mo at INR 2-3– B. 6 mo at INR 2-3– C. 12 mo at INR 2-3– D. 6 mo at INR 2-3, then indefinitely at INR 1.5-2– E. Indefinitely at INR 2-3

Page 26: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Warfarin Therapy

First episode of DVT -- usually 6 monthsDVT due to transient risk factor (Surgery): 3 months of tx may be consideredPREVENT and ELATE have shown that indefinite treatment does decrease the risk of recurrence. They disagree on the necessary target INR.Long-term therapy needs to be balanced against the risk of bleeding.

Page 27: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 9

62 yo w/ recently diagnosed mucinous adenocarcinoma in the liver with no known primary. Presents with syncope, now normotensive, and found to have PE on CT. Treatment?

• A. Start LMWH and warfarin, continue warfarin indefinitely or until cure

• B. Start heparin drip and warfarin, continue warfarin indefinitely.

• C. LMWH indefinitely• D. LMWH for 6 months

Page 28: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

VTE in Cancer Patients

LMWH is better than unfractionated heparin for cancer patients.Antithrombotic and antineoplastic effectsLMWH is better than warfarin for long-term tx in cancer patients (less fatal bleeding)

Page 29: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Scenario 10

You are called to see a post-op pt with a swollen leg. It is indeed swollen, tense and a deep red-purple colour. You note some skin necrosis. An U/S documents DVT. Treatment?– A. IV heparin– B. full-dose Lovenox– C. debride skin– D. thrombectomy

Page 30: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Surgery for DVT

Phlegmasia ceruluea dolens/ venous gangrene is an absolute indication for surgery.Femoral venotomyInterventional radiologyHigh incidence of post-phlebitic syndrome

Page 31: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Other Treatments

Thrombolytics• Controversial• Best evidence in unstable patient with PE• Indicated in massive ileofemoral thrombolysis

and low-risk to bleed

New medications• Fondaparinux• ximelagatran

Page 32: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

IVC Filters

Protect against fatal PEIn general, for use in patients with contraindication to anticoagulationMay consider filter + anticoag is patient with severe cardiopulmonary dz where recurrent PE may be fatal.Information based on poor, older studiesRetrievable filters (new)

Page 33: Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment

Further Info

ACCP Guidelines Chest, Sept 2004, Vol126, supp 3.

AJS 2005, 189:14-25.